Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Bloomberg Customers


February 07, 2016 12:53 PM ET

Biotechnology

Company Overview of Opsona Therapeutics Limited

Company Overview

Opsona Therapeutics Limited operates as a clinical stage biopharmaceutical company. The company primarily focuses on developing drugs for the treatment of autoimmune/inflammatory diseases and inflammatory diseases, transplant rejection, cancer, diabetes, Alzheimer's disease, and atherosclerosis. Its portfolio includes OPN-305, a monoclonal/humanized antibody that reduces pro-inflammatory cytokine production associated with heart and kidney diseases, as well as capable of dampening down the body’s immune response to a donated kidney. The company’s development portfolio includes IL-1ß inhibitors. Opsona Therapeutics Limited was founded in 2004 and is based in Dublin, Ireland.

Second Floor

Ashford House

Tara Street

Dublin,  2

Ireland

Founded in 2004

Phone:

353 1 677 0223

Fax:

353 1 677 8949

Key Executives for Opsona Therapeutics Limited

Chief Executive Officer
Age: 54
Co-Founder and Member of Scientific Advisory Board
Co-Founder and Scientific Advisor
Age: 59
Co-Founder, Chief Scientific Officer and Director
Finance Director
Age: 50
Compensation as of Fiscal Year 2015.

Opsona Therapeutics Limited Key Developments

Opsona Therapeutics Limited Presents at 8th Annual Biotech Showcase Investor Conference 2016, Jan-12-2016 10:30 AM

Opsona Therapeutics Limited Presents at 8th Annual Biotech Showcase Investor Conference 2016, Jan-12-2016 10:30 AM. Venue: Parc 55 San Francisco, 55 Cyril Magnin Street, San Francisco, CA 94102, United States.

Opsona Therapeutics Limited Presents at BIO-Europe 2015, Nov-02-2015

Opsona Therapeutics Limited Presents at BIO-Europe 2015, Nov-02-2015 . Venue: Munich, Germany.

Opsona Therapeutics Limited Presents at Sofinnova Japan Biopharma Partnering Conference 2015, Oct-27-2015 11:45 AM

Opsona Therapeutics Limited Presents at Sofinnova Japan Biopharma Partnering Conference 2015, Oct-27-2015 11:45 AM. Venue: Conrad Hotel, 1-9-1, Higashi-Shinbashi, Minato-Ku, Tokyo, 105 7337, Japan.

Similar Private Companies By Industry

Company Name Region
Genable Technologies Ltd. Europe
Premier Biomaterials Ltd. Europe
SurgaColl Technologies Ltd Europe
Flurocap Ltd. Europe
Elan Capital Corp. Ltd. Europe

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Opsona Therapeutics Limited, please visit www.opsona.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.